Breast Tumor Intrinsic Subtype Classification
Author Information
Author(s): Hu Zhiyuan, Fan Cheng, Oh Daniel S, Marron JS, He Xiaping, Qaqish Bahjat F, Livasy Chad, Carey Lisa A, Reynolds Evangeline, Dressler Lynn, Nobel Andrew, Parker Joel, Ewend Matthew G, Sawyer Lynda R, Wu Junyuan, Liu Yudong, Nanda Rita, Tretiakova Maria, Orrico Alejandra Ruiz, Dreher Donna, Palazzo Juan P, Perreard Laurent, Nelson Edward, Mone Mary, Hansen Heidi, Mullins Michael, Quackenbush John F, Ellis Matthew J, Olopade Olufunmilayo I, Bernard Philip S, Perou Charles M
Primary Institution: University of North Carolina, Chapel Hill
Hypothesis
Can a new breast tumor intrinsic gene list be validated across independent datasets?
Conclusion
The study validates the breast tumor intrinsic subtype classification as a reliable method for tumor classification that can be used in clinical settings.
Supporting Evidence
- The study identified 1300 genes associated with breast tumor subtypes.
- Multivariate analysis showed that intrinsic subtype classifications provided significant prognostic information.
- The new intrinsic gene set was validated across multiple independent datasets.
- Kaplan-Meier survival analysis indicated significant differences in survival based on tumor subtypes.
- The Single Sample Predictor (SSP) consistently predicted survival in treated and untreated patient groups.
- Hierarchical clustering revealed five main breast tumor subtypes.
- Proliferation genes were included in the new intrinsic gene set, indicating their importance in tumor biology.
- Significant associations were found between tumor subtypes and clinical parameters such as grade and ER status.
Takeaway
This study shows that breast tumors can be classified into different types based on their genes, which helps doctors understand how to treat patients better.
Methodology
The study used a training set of 105 tumors to derive a gene list and validated it on a combined test set of 315 tumors using hierarchical clustering and multivariate analysis.
Potential Biases
Potential biases from combining datasets from different laboratories.
Limitations
The study relies on publicly available datasets, which may have variability in sample preparation and experimental design.
Participant Demographics
The study included a diverse cohort of breast cancer patients from multiple institutions.
Statistical Information
P-Value
0.000001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website